Szarkóma: vizsgálatok itt: Egyesült Államok
301 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Where
- Bethesda, Boston, Canton, Chicago, Houston, New York, Portland, Rochester
- Életkor
- 18 év and over
- People
- 16 worldwide
- Run by
- Rezolute
See details and how to joinNCT06881992 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Where
- Aurora, Duarte, Houston, New Haven, San Antonio, Sarasota
- Életkor
- 18 év and over
- People
- 405 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Atlanta, Aurora, Boston, Charlotte, Cleveland, Dallas, Hershey, Houston, Los Angeles, Memphis, New Brunswick, New York, Orlando, Philadelphia, Richmond, Scarborough, St Louis
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Életkor
- 18 év to 130 év
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - 2. fázisTaking peopleA Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
- Where
- Houston
- Életkor
- 18 év and over
- People
- 70
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07193550 - 1. fázisTaking peopleMetastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Where
- Atlanta, Birmingham, Buffalo, Chapel Hill, Charlotte, Cleveland, Columbus, Durham, Gainesville, Grand Rapids, Hartford, Jacksonville, Lexington, Miami, Nashville, Phoenix, Salt Lake City, St. Petersburg, Tampa, The Bronx
- Életkor
- 1 év and over
- People
- 15
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT07194044 - 1. fázisTaking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Korai 1. fázisTaking peopleA Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
- Where
- Baltimore, New York
- Életkor
- 18 év and over
- People
- 24
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06610682 - 1. fázisTaking peopleA Study of CRD3874-SI in People With Solid Tumors
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 81
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06021626 - 1/2. fázisTaking peopleA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Where
- Ann Arbor, Baton Rouge, Boston, Fairfax, Hackensack, Houston, Nashville, New York, Sarasota, Tampa
- Életkor
- 18 év and over
- People
- 265 worldwide
- Run by
- Blueprint Medicines Corporation
See details and how to joinNCT07629960 - No phaseTaking peopleDoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
- Where
- Houston
- Életkor
- 1 év and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07298083 - 1. fázisTaking peopleA Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 18
- Run by
- University of Washington
See details and how to joinNCT06025747 - 1. fázisNot yet taking people in Egyesült ÁllamokEWSR1 Immunotherapy in Ewing Sarcoma and DSRCT
- Where
- Cleveland
- Életkor
- 2 év and over
- People
- 24
- Run by
- Rabi Hanna
See details and how to joinNCT07695311 - 1/2. fázisTaking peopleA Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 54
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06843967 - 3. fázisNot yet taking people in Egyesült ÁllamokPembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 228
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07823491 - 1. fázisTaking peopleA Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
- Where
- Harrison, New York
- Életkor
- 18 év and over
- People
- 40
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05607095 - 2. fázisTaking peopleEvaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- Where
- Houston
- Életkor
- 18 év and over
- People
- 227
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04751409 - No phaseTaking peopleBiomarkers of Resiliency In Childhood Cancer Surgery
- Where
- Rochester
- Életkor
- 3 év to 25 év
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT06674811 - 1/2. fázisTaking peopleFirst-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Where
- Aurora, Houston, Miami, New York
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Adcendo ApS
See details and how to joinNCT06797999 · EU 2024-516900-41-00 - No phaseTaking peopleFinancial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
- Where
- Houston
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07215611 - 1/2. fázisNot yet taking people in Egyesült ÁllamokA Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers
- Where
- Houston
- Életkor
- 18 év and over
- People
- 138
- Run by
- Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT07811232 - 1/2. fázisNot yet taking people in Egyesült ÁllamokA Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers
- Where
- Houston
- Életkor
- 18 év and over
- People
- 138
- Run by
- Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT07811297 - 1. fázisTaking peopleA Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Where
- Fairfax, Houston, Los Angeles, Nashville, San Antonio, Sarasota, St Louis
- Életkor
- 18 év and over
- People
- 80
- Run by
- Angiex, Inc.
See details and how to joinNCT06440005 - 1. fázisTaking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Ann Arbor, Atlanta, Aurora, Beverly Hills, Charlottesville, Chicago, Cincinnati, Cleveland, Duarte, Fairfax, Grand Rapids, Houston, Los Angeles, Nashville, New York, Orange, Philadelphia, Portland, San Antonio, San Diego, San Francisco, Santa Monica, Scottsdale
- Életkor
- 12 év to 85 év
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - 1/2. fázisTaking peopleRetifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- Where
- New York
- Életkor
- 18 év and over
- People
- 98
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04577014